Chair and Scribe: Floyd Eisenberg
Minutes from last call: OMOP Quality Measurement 9 March 2022
Recording of this call (access requires passcode):
- https://us02web.zoom.us/rec/share/IpXBCDJ7BywM08foSDTUkg04kd-vdmvudKp8B73EqRFCy02hTRXal8JkyO6N6GmM.nl1inLRwjkNE4v9q
- Passcode: ^bD3n5p3
Next FHIR-OMOP All Hands Meeting - March 28, 2022 (Monday) 4-5 PM ET - Subgroup leads will provide updates on their progress and 2022 roadmap (primary goals, objectives and deliverables). You can find login details below.
The FHIR-OMOP WG- subgroups are as follows:
- Data Model Harmonization
- Data Quality Measurements
- Terminologies
- Oncology
Zoom Meeting: https://us02web.zoom.us/j/83645856405?pwd=OHJRdVVtb3BBQTdVaWp5UlBXUEdvUT09
Agenda Topic | Discussion Notes | |
---|---|---|
New Discussion Topics/Updates: | ||
Demo: Jack Brewster from IQVIA quick demo to show how to import VSAC into Atlas automatically using R packages. | Jack Brewster provided a demonstration of work to automate the import of VSAC value sets starting with a CSV file and using R packages, process all eCQM value set packages in under 1 hour without any performance issues on the Atlas production environment. This capability is a significant improvement on prior demonstrations of manual mapping to the OMOP concept codes. There were only 2 value set concepts that did not map, the hospital location codes (ICU), for which there is no corresponding concept in OMOP. There were no ambiguous mappings since all involve specific terminology code (SNOMED, LOINC, ICD, CPT, etc.) to OMOP concept codes. The process did not use the VSAC FHIR API but it could be considered as part of the methodology; this effort started with the CSV output from VSAC. A number of participants indicated interest in the code for reuse, and Jack Brewster agreed to make it available for others to use. Refer to the recording of the discussion for specific details. Some specific points in the discussion:
See the recording (referenced at the top of this page) for the detailed conversation and the demonstration. | |
Review of proposed Oncology FHIR-to-OMOP process for May Connectathon to provide context (2022-05 FHIR-OMOP Oncology) | Floyd showed the workflow proposed for the May FHIR Connectathon from the FHIR-OMOP Oncology group (2022-05 FHIR-OMOP Oncology). The flow from left-to-right starts with a provider who (or whose organization) is part of a clinical trial such that entry of data initiates transfer of data to the conversion from FHIR to OMOP. | |
Discussion of OMOP-Atlas to FHIR-CQL conversion | The use case this dQM/OMOP group has designed is the reverse of the FHIR-OMOP Oncology group design, basically requesting all patients who meet criteria for a phenotype defined in Atlas with OMOP and SQL. In the dQM-OMOP workflow, the patients are not known and the retrieve request is to provide all patients meeting criteria for the cohort. Thomas White (MedStar) presented another use case similar to the "gaps in care" approach addressed in Data Exchange for Quality Measures (DEQM), except that all patients meeting the cohort are known in an OMOP data set. The use case uses bulk query to obtain all new data for specific resources for just that patient set (known Atlas-based cohorts) and subsequently uses the retrieved data to determine which patients the existing dataset have gaps in care that can be addressed. Currently FHIR bulk query is not available in all EHRs, it is required by the end of 2022. He noted that the existing dQDM-OMOP use case (I.e., provide all patients meeting a cohort definition) is still critically important; the gaps-in-care use case in an additional requirement for OMOP to FHIR efforts. Paul Denning provided a link to the FHIR Quality Measure IG (the build version to be published very soon: http://build.fhir.org/ig/HL7/cqf-measures/capabilities.html. The directory for published versions is located at http://hl7.org/fhir/us/cqfmeasures/history.html (this new publication should be version 4.1.0). | |
Discussion about potential synthetic patient set in (a) FHIR, (b) OMOP | Not discussed due to lack of time. | |
Follow up next steps from last call (March 9) - validate actions needed: Reminder from last call regarding COVID Criteria for cohort: https://github.com/National-COVID-Cohort-Collaborative/Phenotype_Data_Acquisition/wiki/Latest-Phenotype; Describe requirements for the various components of the architecture - Seeking input from WG members: | No new information about potential participants. The use case remains a valid and useful one based on today's discussion. Will need to add an additional use case to identify gaps-in-care for a known OMOP patient data set, potentially using bulk data requests. | |
Terminology:
| TBD | |
Expression:
| TBD | |
Data Query and Response:
| TBD | |
Next Steps from March 9:
| ||
New Next Steps: | Group members will review capabilities discussed regarding automated mapping of VSAC (or other) value sets to OMOP. Add known OMOP cohort gaps-in-care request as a new OMOP to FHIR use case in addition to the one to identify members of a cohort/phenotype. New Graphic to describe the 2 dQM-OMOP use cases: Continue to generate support for activities. It is unlikely that a May FHIR Connectathon for the OMOP to FHIR use case(s) will be possible but perhaps work can occur in the NCQA/FHIR Digital Quality Summit. | |
Adjournment | Adjourned at 11:02 AM EDT |
Attendees
Attendee | Attendee's Organization | Attendee's email | Present | |
1 | Abdullah Rafiqi | ESAC | yes | |
2 | Andrew Frangleton | ClinicalArchitecture | yes | |
3 | NCQA | |||
4 | Ben Hamlin | NCQA | ||
5 | Bryan Laraway | |||
6 | Alphora | yes | ||
7 | ||||
8 | Johns Hopkins | dgabrie4@jh.edu | yes | |
9 | Dipti Gandhi | |||
10 | Dorothy Lee | NCQA | ||
11 | Edward Smith | |||
12 | Evan Patrick Minty | |||
13 | Floyd Eisenberg | iParsimony, LLC | yes | |
14 | ESAC | |||
15 | Jack Brewster | IQVIA | yes | |
16 | James Brash | |||
17 | Jamie Smith | |||
18 | ||||
19 | John David Evans | |||
20 | JP | yes | ||
21 | Julia Dawson | yes | ||
22 | ||||
23 | Justin McKelvy | |||
24 | Kristin Kostka | yes | ||
25 | Latasha Estrada | |||
26 | Luis Alaniz | |||
27 | ||||
28 | NCQA | |||
29 | Ming Dunajick | |||
30 | ||||
31 | yes | |||
32 | ||||
33 | yes | |||
34 | ||||
35 | yes | |||
36 | Raju Hemadri | |||
37 | ||||
38 | @Sandra Siami | |||
39 | Sebastian van Sandijk | Odysseus | yes | |
40 | Shaun Shakib | yes | ||
41 | Telligen | |||
42 | MedStar Health | yes | ||
43 | Vickie Reyes (GC) | yes | ||
44 | yes | |||
45 | Zhen Lin | yes | ||
46 | JD Liddil | M2GEN | james.liddil@m2gen.com |